Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 13.83 billion as of February 21, 2025. Its market cap has decreased by -5.13% in one year.

Market Cap

13.83B

Enterprise Value

15.88B

Revenue

5.38B

Ranking

n/a

PE Ratio

19.26

Stock Price

32.90

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 13.83B, an increase of 2,269.63%. That is a compound annual growth rate of 18.33%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	13.83B	-4.64%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	6.81B	20.87%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	226.03B
Caliway Biopharmaceuticals	145.92B
Bora Pharmaceuticals Co., LTD.	90.53B
Lotus Pharmaceutical	72.59B
Lumosa Therapeutics	39.94B
Oneness Biotech	38.77B
Polaris Group	36.53B
Pegavision	30.34B

Market Cap Rankings